Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
LY2
HR+
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
10264.011
uM
2.47060
23.53780
-0.6543 -0.9921 0.4850 0.5557
0.9929
1.3983
LY2
HR+
Luminal
Oxamflatin
HDAC
HDAC
12319.147
uM
0.92816
1.95770
-0.8875 -0.9090 1.3881 0.6226
0.9379
1.1783
LY2
HR+
Luminal
Oxamflatin
HDAC
HDAC
10816.147
uM
1.46430
2.2370
-0.9835 -0.9829 2.5654 0.5014
0.9979
0.7283
LY2
HR+
Luminal
PD 98059
MEK
MAPK
10816.152
uM
inf
inf
0.6055 0.6055 0.0000 0.0662
0.4985
1.0111
LY2
HR+
Luminal
PD173074
FGFR1/3
RTK
10380.093
uM
8.16720
9.24270
-0.4195 -0.4220 4.9463 0.0993
0.9928
1.4880
LY2
HR+
Luminal
PD184352
MEK
MAPK
10816.155
uM
inf
inf
0.5413 0.5413 0.0000 0.0964
0.4722
0.8353
LY2
HR+
Luminal
PD184352
MEK
MAPK
10816.155
uM
inf
inf
0.5413 0.5413 0.0000 0.0964
0.4722
0.8353
LY2
HR+
Luminal
PD184352
MEK
MAPK
12319.155
uM
inf
inf
0.7640 0.7640 0.0000 0.0144
0.5546
0.9333
LY2
HR+
Luminal
PD184352
MEK
MAPK
12319.155
uM
inf
inf
0.7640 0.7640 0.0000 0.0144
0.5546
0.9333
LY2
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
10380.095
uM
0.46671
0.30280
0.1161 0.2841 1.9411 0.5166
0.9207
1.4726
LY2
HR+
Luminal
PS-1145
IKK
NFKB
10380.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0461
-60.9713
1.4916
LY2
HR+
Luminal
PS-1145
IKK
NFKB
7477.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7891
LY2
HR+
Luminal
Purvalanol A
CDK1
CDK
7477.067
uM
204.01150
195.37340
0.7169 0.0973 5.0000 -0.0291
0.7971
0.6787
LY2
HR+
Luminal
Ribavirin
15391.211
uM
inf
inf
0.9725 0.9725 0.0000 0.0076
-0.0134
1.2835
LY2
HR+
Luminal
SB-3CT
MMP2/9
MMP
10816.144
uM
inf
inf
0.9453 0.9453 0.0000 -0.0111
-0.0185
0.9146
LY2
HR+
Luminal
SB-3CT
MMP2/9
MMP
12319.168
uM
6.1160
9.60070
-0.9871 -0.9793 2.4054 0.4732
0.9758
0.9560
LY2
HR+
Luminal
Selumetinib
MEK
MAPK
10816.155
uM
inf
inf
0.9135 0.9135 0.0000 0.1047
0.4006
0.8353
LY2
HR+
Luminal
Selumetinib
MEK
MAPK
12319.155
uM
inf
inf
0.6784 0.6784 0.0000 0.1879
0.5014
0.9333
LY2
HR+
Luminal
Sigma A6730
AKT
AKT
12319.165
uM
1.09610
3.0440
-0.9869 -1.0000 1.0756 0.6110
0.8753
0.9117
LY2
HR+
Luminal
Sigma A6730
AKT
AKT
10816.153
uM
1.79770
3.82850
-0.9957 -1.0000 1.4532 0.4976
0.9581
0.7704
LY2
HR+
Luminal
Sirolimus
MTOR
MTOR
7865.068
uM
inf
inf
-0.1814 -0.1814 0.0000 0.5691
0.4192
1.5516
LY2
HR+
Luminal
Sirolimus
MTOR
MTOR
7477.069
uM
0.11419
0.13814
-0.1474 -0.0370 0.3746 0.4594
0.7973
1.6157
LY2
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7477.084
uM
inf
inf
1.0500 1.0500 0.0000 -0.0334
-0.0852
0.9476
LY2
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7477.067
uM
6.0510
7.53770
-0.9999 -0.9998 5.0000 0.4399
0.9978
0.6787
LY2
HR+
Luminal
Taxol
TUBB
TUBB
10264.002
uM
0.01167
0.01092
-0.1629 0.0626 1.9986 0.5515
0.9562
1.2356